Brief: Citadel Advisors Reports 6.4% Passive Stake In Atara Biotherapeutics As Of March 8 - SEC Filing
March 18 (Reuters) - Atara Biotherapeutics Inc ATRA.O :
* CITADEL ADVISORS LLC REPORTS 6.4% PASSIVE STAKE IN ATARA
BIOTHERAPEUTICS INC AS OF MARCH 8 - SEC FILING
Source text for Eikon: ID:n0001104659-24-035552
Further company coverage: ATRA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Atara Biotherapeutics
See all newsBrief: Atara Biotherapeutics - May Offer Up To $79.27 Million In Common Stock As Of May 12, 2026 - SEC Filing
Atara Biotherapeutics Q1 revenue drops after prior-year one-time gain
Brief: Atara Biotherapeutics Q1 EPS USD -0.29
NASDAQ RESUMED AT 03:40 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 03:30 PM